Entrectinib in ROS1 fusion-positive non-small-cell lung cancer: integrated analysis of three phase 1–2 trials
Journal
The Lancet Oncology
Journal Volume
21
Journal Issue
2
Pages
261-270
Date Issued
2020
Author(s)
Drilon A.
Siena S.
Dziadziuszko R.
Barlesi F.
Krebs M.G.
Shaw A.T.
de Braud F.
Rolfo C.
Ahn M.-J.
Wolf J.
Seto T.
Cho B.C.
Patel M.R.
Chiu C.-H.
John T.
Goto K.
Karapetis C.S.
Arkenau H.-T.
Kim S.-W.
Ohe Y.
Li Y.-C.
Chae Y.K.
Chung C.H.
Otterson G.A.
Murakami H.
Tan D.S.W.
Prenen H.
Riehl T.
Chow-Maneval E.
Simmons B.
Cui N.
Johnson A.
Eng S.
Wilson T.R.
Doebele R.C.
SDGs
Publisher
Lancet Publishing Group
Type
journal article